Now showing items 1-6 of 6

    • Applying medicines reconciliation indicators in two UK hospitals: a feasibility study 

      Aljamal, Mohammed S.; Abdel-Qader, Derar H.; Al Meslamani, Ahmad Z. (Oxford University Press, 2021)
      ObjectivesThe aim of this study was to apply the Medicines reconciliation (MR) indicators and to assess their feasibility for use with patients on admission. MethodsThis is a mixed-methods study conducted in two large ...
    • Evaluation of Telepharmacy Services in Light of COVID-19 

      Ibrahim, Osama Mohamed; Ibrahim, Rana M.; Abdel-Qader, Derar H.; Al Meslamani, Ahmad Z.; Al Mazrouei, Nadia (Mary Ann Liebert Inc., 2021)
      Background: Telepharmacy services are expected to have an important role in increasing access of patients to pharmaceutical care and reducing potential dispensing errors in community pharmacies. Objective: To assess the ...
    • The evolving role of community pharmacists during COVID-19 in the UAE; assessing preparedness and knowledge 

      Al Mazrouei, Nadia; Ibrahim, Rana M.; Al Meslamani, Ahmad Z.; Abdel-Qader, Derar H.; Sadeq, Adel Shaban; Ibrahim, Osama Mohamed (Oxford University Press, 2021)
      Objectives To investigate community pharmacists' knowledge about COVID-19 and their preparedness for the pandemic. Methods This cross-sectional online survey was conducted (in community pharmacies in the United Arab Emirates) ...
    • Investigating prescribing errors in the emergency department of a large governmental hospital in Jordan 

      Abdel-Qader, Derar H.; Al Meslamani, Ahmad Z.; El-Shara, Asma’ A.; Ismael, Najlaa Saadi; Albassam, Abdullah; Lewis, Penny J.; Hamadi, Salim; Abbas, Hazim Saleem; Al Mazrouei, Nadia; Ibrahim, Osama Mohamed (Blackwell Publishing Ltd., 2020)
      Background: Although prescribing errors (PEs) are the most common type of medication errors and cause morbidity and mortality, they have been rarely studied. Objective: The study aimed to investigate PEs incidence, types, ...
    • Letter to the Editor.... IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine 

      Abdel-Qader, Derar H.; Alkhatatbeh, Issa Hazza; Hayajneh, Wail; Annab, Hassan; Al Meslamani, Ahmad Z.; Elmusa, Reem A. (Elsevier Ltd, 2022)
      The Pfizer-BioNTech vaccine (BNT162b2 mRNA) against coronavirus disease 2019 (COVID-19) was granted the US Food and Drug Administration’s emergency use authorization in December 2020 for individuals aged ≥ 16 years; this ...
    • Pharmacists-physicians collaborative intervention to reduce vaccine hesitancy and resistance: A randomized controlled trial 

      Abdel-Qader, Derar H.; Hayajneh, Wail; Albassam, Abdullah; Obeidat, Nathir M.; Belbeisi, Adel M.; Al Mazrouei, Nadia; Al-Shaikh, Ala’a F.; Nusair, Khaldoon E.; Al Meslamani, Ahmad Z.; El-Shara, Asma A.; El Sharu, Husam; Ebaed, Samah Bahy Mohammed; Ibrahim, Osama Mohamed (Elsevier Ltd, 2022)
      Purpose: Given their negative influence on community health, vaccine hesitancy and resistance are emerging challenges that require healthcare intervention. Therefore, this study aimed to assess the impact of physician-pharmacist ...